Spermosens AB (SPERM.ST)

SEK 0.01

(-3.23%)

Market Cap (In SEK)

8.5 Million

Revenue (In SEK)

-

Net Income (In SEK)

-12.2 Million

Avg. Volume

1.84 Million

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.009028-0.835
PE
-
EPS
-
Beta Value
-0.236
ISIN
SE0015346424
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Tore Duvold
Employee Count
-
Website
https://www.spermosens.com
Ipo Date
2021-05-19
Details
Spermosens AB engages in the research, development, and commercialization of diagnostic technology in health and medical care in Sweden. The company provides male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. The company was incorporated in 2018 and is based in Lund, Sweden.